Researchers at Portugal's Champalimaud Foundation said Friday that the molecule of serotonin in the organism can diminish sensitivity to pain.
"The effect of the liberation of serotonin was clear. The rats we stimulated with serotonin revealed a significative decrease in sensibility to pain, when we compared them to the rats in the control group," Xinhua quoted Guillaume Dugue, one of the researchers, as saying in a press release.
The results found by the scientists, led by Champalimaud Foundation Neuroscience Programme Director Zachary Mainen, were published in the scientific magazine Plos One Friday.
"There is still yet a lot of work to do to understand the effects of serotonin, but one day methods like this will be used to control situations like chronic pain," Mainen told Portuguese Lusa news agency.
He added that the team had taken another step to understanding the physiological role of this molecule.
Champalimaud Foundation is a biomedical research unit based in Portuguese capital Lisbon.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
